CVA Family Office’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.3K Buy
471
+60
+15% +$4.38K ﹤0.01% 671
2026
Q1
$26.8K Sell
411
-275
-40% -$20.4K ﹤0.01% 729
2025
Q4
$54.4K Hold
686
0.01% 538
2025
Q3
$50.1K Hold
686
0.01% 553
2025
Q2
$52K Sell
686
-7
-1% -$496 0.01% 540
2025
Q1
$52.7K Sell
693
-85
-11% -$6.33K 0.01% 509
2024
Q4
$51.4K Sell
778
-79
-9% -$5.53K 0.01% 519
2024
Q3
$59.8K Sell
857
-1
-0.1% -$60 0.01% 473
2024
Q2
$45.4K Buy
+858
New +$52.1K 0.01% 514

Other funds holding SOLV

CVA Family Office's SOLV Position: Q2 2026 in Review

CVA Family Office increased its Solventum (SOLV) stake by 15% in Q2 2026, buying an estimated $4.38K and bringing the position to 471 shares worth $36.3K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

CVA Family Office first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $59.8K in Q3 2024. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • CVA Family Office held 471 shares of Solventum worth $36.3K as of Q2 2026.
  • CVA Family Office bought 60 Solventum shares in Q2 2026, an estimated $4.38K.
  • Solventum made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #671 holding.
  • CVA Family Office first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • CVA Family Office's Solventum position peaked at $59.8K in Q3 2024.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.